Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03107845Not ApplicableCompleted

Randomized Controlled Trial to Evaluate Personalized Prediction and Adaptation Tools in Psychotherapy

Role: lead

NCT03119298Completed

Measuring Fear of Physical Activity in Patients With Heart Failure

Role: lead

NCT02898246Completed

Fear of Activity in Situations (FActS) - Study 2016

Role: lead

NCT02270073Not ApplicableCompleted

The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study

Role: collaborator

NCT01331759Not ApplicableCompleted

Neuropattern™ for Workplace Health Promotion

Role: collaborator

NCT01062880Not ApplicableUnknown

Neuropattern - Assessment of a Translational Diagnostic Tool for Depression, Adjustment- and Somatoform-disorders

Role: lead

All 6 trials loaded